Want to see JP:9267 full AI Analyst Report?
9267 Stock Chart & Stats
¥4960.00
-¥60.00(-1.91%)
At close: 4:00 PM EST
¥4960.00
-¥60.00(-1.91%)
Day’s Range― - ―
52-Week Range¥3,175.00 - ¥5,460.00
Previous CloseN/A
Volume44.10K
Average Volume (3M)62.69K
Market Cap
¥115.90B
Enterprise Value¥144.04K
Total Cash (Recent Filing)¥11.39B
Total Debt (Recent Filing)¥38.60B
Price to Earnings (P/E)14.7
Beta0.38
Next Earnings
Jul 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.25%
Share Statistics
EPS (TTM)256.75
Shares Outstanding31,042,568
10 Day Avg. Volume60,060
30 Day Avg. Volume62,690
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)2.17
Price to Sales (P/S)0.58
P/FCF Ratio-46.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)280.8
Revenue Forecast (FY)¥241.10B
Bulls Say, Bears Say
Bulls Say
Revenue & Margin TrendsConsistent revenue growth with gross margin around 20% and improving net margin indicates durable pricing power and operational efficiency. Over the next 2–6 months, this supports sustained earnings resilience across stores and product mix, cushioning against cyclical pressures.
Balance Sheet StrengthA moderate debt-to-equity ratio and strong ROE signal a balanced capital structure and efficient use of shareholder equity. This provides financial flexibility for investments or weathering revenue dips without excessive refinancing risk, supporting long-term operational stability.
Operating Cash GenerationHealthy operating cash flow shows the core retail business converts sales into cash reliably, underpinning day-to-day funding and working capital. If managed, this recurring cash generation can finance inventory and modest capex and supports continuity of operations.
Bears Say
Negative Free Cash FlowA large drop in free cash flow is a material structural concern: after capex the business is consuming cash, which may constrain reinvestment, dividends, or debt reduction. Persistent negative FCF would force reliance on financing or asset sales, reducing strategic optionality.
Minimal Dividend IncomeA very low dividend yield suggests limited shareholder cash returns and may reflect constrained free cash deployment. For income-focused investors, this reduces the stock's appeal and signals management prioritizes other uses or lacks excess distributable cash in the near term.
Reliance On Physical Foot TrafficBusiness dependence on in-store foot traffic and repeat visits creates structural exposure to changing consumer behavior and channel shifts to e-commerce. Without stronger omni-channel initiatives, sustained traffic declines would pressure sales and margins over the medium term.
Genky DrugStores Co., Ltd. News
9267 FAQ
What was Genky DrugStores Co., Ltd.’s price range in the past 12 months?
Genky DrugStores Co., Ltd. lowest stock price was ¥3175.00 and its highest was ¥5460.00 in the past 12 months.
What is Genky DrugStores Co., Ltd.’s market cap?
Genky DrugStores Co., Ltd.’s market cap is ¥115.90B.
When is Genky DrugStores Co., Ltd.’s upcoming earnings report date?
Genky DrugStores Co., Ltd.’s upcoming earnings report date is Jul 28, 2026 which is in 8 days.
How were Genky DrugStores Co., Ltd.’s earnings last quarter?
Genky DrugStores Co., Ltd. released its earnings results on Apr 28, 2026. The company reported ¥52.49 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Genky DrugStores Co., Ltd. overvalued?
According to Wall Street analysts Genky DrugStores Co., Ltd.’s price is currently Overvalued.
Does Genky DrugStores Co., Ltd. pay dividends?
Genky DrugStores Co., Ltd. pays a Semiannually dividend of ¥6.5 which represents an annual dividend yield of 0.25%. See more information on Genky DrugStores Co., Ltd. dividends here
What is Genky DrugStores Co., Ltd.’s EPS estimate?
Genky DrugStores Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genky DrugStores Co., Ltd. have?
Genky DrugStores Co., Ltd. has 31,042,568 shares outstanding.
What happened to Genky DrugStores Co., Ltd.’s price movement after its last earnings report?
Genky DrugStores Co., Ltd. reported an EPS of ¥52.49 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.135%.
Which hedge fund is a major shareholder of Genky DrugStores Co., Ltd.?
Currently, no hedge funds are holding shares in JP:9267
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. engages in the management and operation of food and drug chain stores in Japan. Genky DrugStores Co., Ltd. was founded in 1988 and is headquartered in Sakai, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―